The CA-IX protein, a direct transcriptional target of HIF-1 and one of the most prominent intrinsic markers of tumor hypoxia [9,10], has been determined to participate in numerous basic physiological functions and cancer processes [11], and can serve as a surrogate marker for the transcriptional activity of HIF-1 in solid tumors [12]. The gene discussed is HIF1A; the disease is cancer.